Brand New US-Based Pharmaceutical Manufacturer Medivant Healthcare Rolls Out Sterile Single Dose Liquid Injectable Medications to Fill the FDA's Drug Shortage List

SourcePR Newswire
Date Published05/04/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Medivant Healthcare
Parent companyTailstorm Health, Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):25
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:In-house
City reshored to:Chandler
State(s) reshored to:AZ
If relevant, work nearshored to:-
Product(s) reshoredsingle dose liquid injectable medications
What non-domestic negative factors made offshoring less attractive?Quality/rework/warranty
What domestic positive factors made reshoring more attractive?Automation/technology, Impact on domestic economy, covid-19, hospital drug shortage
Find Reshoring Articles